Interaction of non-human primate complement and antibodies with hypermucoviscous Klebsiella pneumoniae

Esteban Soto Martinez, Sylvia Marchi, Amy Beierschmitt, Michael Kearney, Stewart Francis, Kimberly Vanness, Michel Vandenplas, Maryanna Thrall, Roberta Palmour

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Emergent hypermucoviscosity (HMV) phenotypes of Klebsiella pneumoniae have been associated with increased invasiveness and pathogenicity in primates. In this study, we investigated the interaction of African green monkeys (AGM) (Chlorocebus aethiops sabaeus) complement and antibody with HMV and non-HMV isolates as in vitro models of primate infection. Significantly greater survival of HMV isolates was evident after incubation in normal serum or whole blood (p < 0.05) of AGM donors when compared to non-HMV strains. Greater survival of HMV strains (p < 0.05) was found after incubation in whole blood and serum from seropositive donors when compared to seronegative donor samples. Additionally, significantly greater amounts of K. pneumoniae were phagocytozed by AGM leukocytes when complement was active (p < 0.05), but no difference in uptake was observed when serum from seropositive or seronegative animals was used in challenged cells utilizing flow cytometry. Results demonstrate that interaction of cellular and humoral immune elements play a role in the in vitro killing of K. pneumoniae, particularly HMV isolates. Neither AGM serum, nor washed whole blood effectively killed HMV isolates; however, assays using heparinized whole blood of seronegative donors significantly reduced viability of HMV and non-HMV strains. The lack of bacterial killing observed in seropositive donors treatments could be at least partially associated with low IgG2 present in these animals. A better understanding of the pathogenesis of klebsiellosis in primates and host immune response is necessary to identify surface molecules that can induce both opsonizing and bactericidal antibody facilitating killing of Klebsiella, and the development of vaccines in human and animals.

Original languageEnglish (US)
Article number01603251
JournalVeterinary Research
Volume47
Issue number1
DOIs
StatePublished - 2016

Fingerprint

Cercopithecus aethiops
Klebsiella pneumoniae
Primates
complement
blood serum
antibodies
Tissue Donors
Antibodies
blood
Serum
animals
Klebsiella
Survival
vaccine development
Blood Donors
flow cytometry
Virulence
leukocytes
Flow Cytometry
Leukocytes

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Interaction of non-human primate complement and antibodies with hypermucoviscous Klebsiella pneumoniae. / Soto Martinez, Esteban; Marchi, Sylvia; Beierschmitt, Amy; Kearney, Michael; Francis, Stewart; Vanness, Kimberly; Vandenplas, Michel; Thrall, Maryanna; Palmour, Roberta.

In: Veterinary Research, Vol. 47, No. 1, 01603251, 2016.

Research output: Contribution to journalArticle

Soto Martinez, E, Marchi, S, Beierschmitt, A, Kearney, M, Francis, S, Vanness, K, Vandenplas, M, Thrall, M & Palmour, R 2016, 'Interaction of non-human primate complement and antibodies with hypermucoviscous Klebsiella pneumoniae', Veterinary Research, vol. 47, no. 1, 01603251. https://doi.org/10.1186/s13567-016-0325-1
Soto Martinez, Esteban ; Marchi, Sylvia ; Beierschmitt, Amy ; Kearney, Michael ; Francis, Stewart ; Vanness, Kimberly ; Vandenplas, Michel ; Thrall, Maryanna ; Palmour, Roberta. / Interaction of non-human primate complement and antibodies with hypermucoviscous Klebsiella pneumoniae. In: Veterinary Research. 2016 ; Vol. 47, No. 1.
@article{5ac050d78a494556b5cf669fa0fc2625,
title = "Interaction of non-human primate complement and antibodies with hypermucoviscous Klebsiella pneumoniae",
abstract = "Emergent hypermucoviscosity (HMV) phenotypes of Klebsiella pneumoniae have been associated with increased invasiveness and pathogenicity in primates. In this study, we investigated the interaction of African green monkeys (AGM) (Chlorocebus aethiops sabaeus) complement and antibody with HMV and non-HMV isolates as in vitro models of primate infection. Significantly greater survival of HMV isolates was evident after incubation in normal serum or whole blood (p < 0.05) of AGM donors when compared to non-HMV strains. Greater survival of HMV strains (p < 0.05) was found after incubation in whole blood and serum from seropositive donors when compared to seronegative donor samples. Additionally, significantly greater amounts of K. pneumoniae were phagocytozed by AGM leukocytes when complement was active (p < 0.05), but no difference in uptake was observed when serum from seropositive or seronegative animals was used in challenged cells utilizing flow cytometry. Results demonstrate that interaction of cellular and humoral immune elements play a role in the in vitro killing of K. pneumoniae, particularly HMV isolates. Neither AGM serum, nor washed whole blood effectively killed HMV isolates; however, assays using heparinized whole blood of seronegative donors significantly reduced viability of HMV and non-HMV strains. The lack of bacterial killing observed in seropositive donors treatments could be at least partially associated with low IgG2 present in these animals. A better understanding of the pathogenesis of klebsiellosis in primates and host immune response is necessary to identify surface molecules that can induce both opsonizing and bactericidal antibody facilitating killing of Klebsiella, and the development of vaccines in human and animals.",
author = "{Soto Martinez}, Esteban and Sylvia Marchi and Amy Beierschmitt and Michael Kearney and Stewart Francis and Kimberly Vanness and Michel Vandenplas and Maryanna Thrall and Roberta Palmour",
year = "2016",
doi = "10.1186/s13567-016-0325-1",
language = "English (US)",
volume = "47",
journal = "Annales de Recherches Veterinaires",
issn = "0928-4249",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Interaction of non-human primate complement and antibodies with hypermucoviscous Klebsiella pneumoniae

AU - Soto Martinez, Esteban

AU - Marchi, Sylvia

AU - Beierschmitt, Amy

AU - Kearney, Michael

AU - Francis, Stewart

AU - Vanness, Kimberly

AU - Vandenplas, Michel

AU - Thrall, Maryanna

AU - Palmour, Roberta

PY - 2016

Y1 - 2016

N2 - Emergent hypermucoviscosity (HMV) phenotypes of Klebsiella pneumoniae have been associated with increased invasiveness and pathogenicity in primates. In this study, we investigated the interaction of African green monkeys (AGM) (Chlorocebus aethiops sabaeus) complement and antibody with HMV and non-HMV isolates as in vitro models of primate infection. Significantly greater survival of HMV isolates was evident after incubation in normal serum or whole blood (p < 0.05) of AGM donors when compared to non-HMV strains. Greater survival of HMV strains (p < 0.05) was found after incubation in whole blood and serum from seropositive donors when compared to seronegative donor samples. Additionally, significantly greater amounts of K. pneumoniae were phagocytozed by AGM leukocytes when complement was active (p < 0.05), but no difference in uptake was observed when serum from seropositive or seronegative animals was used in challenged cells utilizing flow cytometry. Results demonstrate that interaction of cellular and humoral immune elements play a role in the in vitro killing of K. pneumoniae, particularly HMV isolates. Neither AGM serum, nor washed whole blood effectively killed HMV isolates; however, assays using heparinized whole blood of seronegative donors significantly reduced viability of HMV and non-HMV strains. The lack of bacterial killing observed in seropositive donors treatments could be at least partially associated with low IgG2 present in these animals. A better understanding of the pathogenesis of klebsiellosis in primates and host immune response is necessary to identify surface molecules that can induce both opsonizing and bactericidal antibody facilitating killing of Klebsiella, and the development of vaccines in human and animals.

AB - Emergent hypermucoviscosity (HMV) phenotypes of Klebsiella pneumoniae have been associated with increased invasiveness and pathogenicity in primates. In this study, we investigated the interaction of African green monkeys (AGM) (Chlorocebus aethiops sabaeus) complement and antibody with HMV and non-HMV isolates as in vitro models of primate infection. Significantly greater survival of HMV isolates was evident after incubation in normal serum or whole blood (p < 0.05) of AGM donors when compared to non-HMV strains. Greater survival of HMV strains (p < 0.05) was found after incubation in whole blood and serum from seropositive donors when compared to seronegative donor samples. Additionally, significantly greater amounts of K. pneumoniae were phagocytozed by AGM leukocytes when complement was active (p < 0.05), but no difference in uptake was observed when serum from seropositive or seronegative animals was used in challenged cells utilizing flow cytometry. Results demonstrate that interaction of cellular and humoral immune elements play a role in the in vitro killing of K. pneumoniae, particularly HMV isolates. Neither AGM serum, nor washed whole blood effectively killed HMV isolates; however, assays using heparinized whole blood of seronegative donors significantly reduced viability of HMV and non-HMV strains. The lack of bacterial killing observed in seropositive donors treatments could be at least partially associated with low IgG2 present in these animals. A better understanding of the pathogenesis of klebsiellosis in primates and host immune response is necessary to identify surface molecules that can induce both opsonizing and bactericidal antibody facilitating killing of Klebsiella, and the development of vaccines in human and animals.

UR - http://www.scopus.com/inward/record.url?scp=84988620148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988620148&partnerID=8YFLogxK

U2 - 10.1186/s13567-016-0325-1

DO - 10.1186/s13567-016-0325-1

M3 - Article

C2 - 26951091

AN - SCOPUS:84988620148

VL - 47

JO - Annales de Recherches Veterinaires

JF - Annales de Recherches Veterinaires

SN - 0928-4249

IS - 1

M1 - 01603251

ER -